KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway
Meng Zhai(Second Affiliated Hospital of Xi'an Jiaotong University), Ju Bai(Second Affiliated Hospital of Xi'an Jiaotong University), Fangmei Li(Second Affiliated Hospital of Xi'an Jiaotong University), Aili He(Second Affiliated Hospital of Xi'an Jiaotong University), Jiyu Miao(Xi'an Jiaotong University), Ting Wang(University of Science and Technology of China), Rui Liu(Xiamen University), Ying Shen(Second Affiliated Hospital of Xi'an Jiaotong University), Ru Zhang(Chongqing University), Xuezhu Xu(King Abdullah University of Science and Technology), Gongzhizi Gao(Second Affiliated Hospital of Xi'an Jiaotong University), Jinsong Hu(Xi'an Jiaotong University)
Cited by 4
Related Papers
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
|Cancer Letters|2020|586
Circles reshaping the RNA world: from waste to treasure
|Molecular Cancer|2017|413